Skip to content

Clinical trials

Mesothelioma trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mesothelioma Country / region: Canada Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20051
20062
20071
20091
20121
20131
20154
20162
20192
20203
20211
20221
20232
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Terminated8
Active, not recruiting5
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
University Health Network, Toronto3
Seagen, a wholly owned subsidiary of Pfizer2
AHS Cancer Control Alberta1
AbbVie1
AstraZeneca1
Bayer1
Boehringer Ingelheim1
British Columbia Cancer Agency1
Canadian Cancer Trials Group1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mesothelioma24
Carcinoma, Non-Small-Cell Lung9
Lung Neoplasms7
Melanoma5
Ovarian Neoplasms5
Colorectal Neoplasms4
Mesothelioma, Malignant4
Carcinoma, Renal Cell3
Cholangiocarcinoma3
Neoplasms3

Trials

Showing 26 to 24 of 24. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.